Evaluate the Efficacy and Safety of GZR33 Injection in Patients With Type 2 Diabetes

Clinical trial NCT07527078 · RECRUITING

Trial details

NCT number: NCT07527078
Sponsor: Gan & Lee Pharmaceuticals.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes (T2DM)

Start date: 2026-04-07
Primary completion: 2026-04-07
Enrollment: 350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.